Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sharfstein Suggests Requiring Supplements Registration, Testing Standards

This article was originally published in The Tan Sheet

Executive Summary

Oversight authorized by DSHEA “is not the regulatory system for dietary supplements sold to the American public,” says former FDA official Joshua Sharfstein.

You may also be interested in...



FDA Warnings Mark Tip Of Iceberg For Stimulant-Spiked Supplements – Study

Researchers' "particular concern" about the stimulant oxilofrine in sports nutrition supplements is that more than 1m youth athletes use the products. Based on labeling, adolescents could consume three times the highest pediatric dose allowed where oxilofrine is approved as a drug.

Federal Sweep Nets 40 Criminal, Civil Cases For Spiked Supplements, Disease Claims

A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.

Federal Sweep Nets 40 Criminal, Civil Cases For Spiked Supplements, Disease Claims

A deputy assistant attorney general clarifies that ongoing investigations target “unlawful makers and marketers of dietary supplements,” but DoJ and other agencies broadly warn the entire industry about the potential for additional criminal cases as well as civil complaints.

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel